|
ZNF512B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.99990000022177E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26319999963032E-07 |
| Normal-vs-Stage2 |
1.064170E-01 |
| Normal-vs-Stage3 |
1.395180E-03 |
| Normal-vs-Stage4 |
9.579800E-03 |
| Stage1-vs-Stage2 |
9.898100E-02 |
| Stage1-vs-Stage3 |
3.956200E-01 |
| Stage1-vs-Stage4 |
1.684650E-01 |
| Stage2-vs-Stage3 |
3.847200E-01 |
| Stage2-vs-Stage4 |
6.488400E-01 |
| Stage3-vs-Stage4 |
6.052600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.39159999999972E-05 |
| Normal-vs-AfricanAmerican |
9.44670000002645E-08 |
| Normal-vs-Asian |
9.373600E-02 |
| Caucasian-vs-AfricanAmerican |
5.7588999999969E-05 |
| Caucasian-vs-Asian |
6.830000E-02 |
| AfricanAmerican-vs-Asian |
8.622200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.661900E-03 |
| Normal-vs-Female |
1.38460021226194E-10 |
| Male-vs-Female |
2.04120000002472E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.306620E-01 |
| Normal-vs-Age(41-60Yrs) |
3.64569999966591E-07 |
| Normal-vs-Age(61-80Yrs) |
1.350510E-04 |
| Normal-vs-Age(81-100Yrs) |
4.291200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.888800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.729800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.641600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.654230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.20099999999057E-05 |
| Normal-vs-Grade 2 |
3.57780000004304E-06 |
| Normal-vs-Grade 3 |
1.023400E-04 |
| Normal-vs-Grade 4 |
9.105900E-02 |
| Grade 1-vs-Grade 2 |
3.357700E-04 |
| Grade 1-vs-Grade 3 |
2.23520000000033E-05 |
| Grade 1-vs-Grade 4 |
1.00179999995564E-06 |
| Grade 2-vs-Grade 3 |
4.475000E-01 |
| Grade 2-vs-Grade 4 |
6.915500E-02 |
| Grade 3-vs-Grade 4 |
1.700230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.88329999994963E-06 |
| Normal-vs-ccB subtype |
1.149870E-02 |
| ccA subtype-vs-ccB subtype |
5.917500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.96569999999907E-05 |
| Normal-vs-N1 |
2.164000E-01 |
| N0-vs-N1 |
6.895400E-01 |
|
|
